Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hereditary Sensory and Autonomic Neuropathies × obinutuzumab × 1 year × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 42 Lymphoma, Follicular 23 Lymphoma, Non-Hodgkin 17 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma 12 Lymphoma, Mantle-Cell 11 Lymphoma, B-Cell, Marginal Zone 11 Recurrence 8 Lymphoma, B-Cell 7 Neoplasms 6 Burkitt Lymphoma 5 Neoplasm, Residual 3 Leukemia, Hairy Cell 3 Leukemia, B-Cell 2 Leukemia 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Part1: Advanced B-cell Malignancies 1 Ovarian Neoplasms 1 Mycosis Fungoides 1 Mesothelioma 1 Melanoma 1 Mature B-cell Malignancies 1 Lymphoma, T-Cell, Cutaneous 1 Lymphatic Diseases 1 Leukemia, Prolymphocytic 1 Hodgkin Disease 1

Interventions

Fulvestrant 3 Letrozole 2 Alpelisib 2 venetoclax 1 tivozanib 1 tipifarnib 1 sotorasib 1 serabelisib 1 sapanisertib 1 ribociclib 1 pembrolizumab 1 palbociclib 1 niraparib 1 exemestane 1 ceralasertib 1 cemiplimab 1 capivasertib 1 Trimetazidine 1 Secretin 1 STX-478 1 Radiotherapy 1 Pharmaceutical Preparations 1 Paclitaxel 1 Nivolumab 1 Leuprolide 1 Irinotecan 1 Goserelin 1 Gemcitabine 1 CA-4948 1 CA-19-9 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡